Table 5B.
Cardiopulmonary changes during heartworm adulticide treatment in dogs, for control groups from studies of moxidectin and doxycycline.
| References | Study protocol | Exercise restriction | Summary findings |
|---|---|---|---|
| Savadelis et al. (31, 53) | EI Untreated controls (n = 8) | Moderate; housed in runs, in pairs | •Cough in 1/8 |
| Paterson et al. (9) | NI 2-dose melarsomine without doxy (n = 15) | Recommended, but many were free-roaming | •One developed hemoptysis on day 9 and required prednisone •One developed tachypnea after the first melarsomine injection |
| Genchi et al. (52) | NI 3-dose melarsomine without doxy (n = 6) | Not stated | Interstitial lung scores on radiographs, worst possible score 3/3. Echo scores based on pulmonary hypertension, worst possible score 3/3 •Two dogs (33%) progressed radiographically from 0/3 to 1/3 at 12 months •All radiographic scores normal at 12 and 18 months •Two had pulmonary hypertension (1/3) at enrollment and 6 months; 1 developed mild new pulmonary hypertension at 6 months (0.5/3) •All other echo scores normal at all time points |
NI, natural infection; EI, experimental infection; echo, echocardiogram/echocardiographic.